Yoram Friedman, MD

Yoram Friedman, MD

(102)

Physician and enterprise product leader. Author of the Agentic AI for Product Leaders series. Writes on AI, healthcare, and what changes when software starts acting. 15+ years at SAP, Walmart, and regulated health tech.

The Last Generation That Can Supervise AI

The Last Generation That Can Supervise AI

We are running an experiment on human oversight without a control group, without outcome tracking, and without a policy framework designed for the result. The current generation of experts may be the last one capable of catching what AI gets wrong.

The Study That Finally Earns the Conclusion

The Study That Finally Earns the Conclusion

Most AI clinical studies measured the wrong thing. They constrained the reasoning mechanism and then evaluated what was left. The Brodeur Science paper finally tests the model the way medicine actually works. The results are hard to dismiss.

The Guide Is Not the Business

The Guide Is Not the Business

Amazon owns the patient at the moment of health decision intent. OpenEvidence owns the physician at the moment of prescribing intent. Both are monetized by the same pharmaceutical industry. The prescription is the handshake between them.

What CEOs Need to Know to Win the AI Bloodbath

What CEOs Need to Know to Win the AI Bloodbath

Most CEOs are optimizing for when the agent ships. The question that matters is what the customer experiences during the rollback. Five things the current agentic AI plan is missing, and the four questions the CEO should be asking before any agent ships.

The Framework Assumes Someone Is Watching

The Framework Assumes Someone Is Watching

Healthcare regulation still assumes a clinician is watching the AI before anything happens. That assumption worked when AI meant a score on a screen. It breaks down when AI runs continuously in a patient's pocket, shaping decisions no one reviews.